Literature DB >> 24385333

Novel predictors of peritonitis-related outcomes in the BRAZPD cohort.

Thyago Proença de Moraes1, Marcia Olandoski, Jaqueline C T Caramori, Luis C Martin, Natália Fernandes, José Carolino Divino-Filho, Roberto Pecoits-Filho, Pasqual Barretti.   

Abstract

INTRODUCTION: Peritonitis remains the main cause of peritoneal dialysis (PD) technique failure worldwide, despite significant reductions in infection rates observed over the past decades. Several studies have described risk factors for peritonitis, technique failure and mortality. However, there are scarce data regarding predictors of complications during and after a peritonitis episode. The aim of our study was to analyze predictors of peritonitis-related outcome in the Brazilian Peritoneal Dialysis study (BRAZPD) cohort.
METHODS: All adult incident patients recruited in the BRAZPD Study between December 2004 and October 2007, who remained at least 90 days on PD and presented their first peritonitis episode (n = 474 patients) were included in the study. The endpoints analyzed were non-resolution, death due to a peritonitis episode and long-term technique survival after a peritonitis episode.
RESULTS: In the multivariable regression, non-resolution was independently associated with older age (odds ratio (OR) 1.02; p < 0.01), collagenosis as the primary renal disease (OR 4.6; p < 0.05) and Pseudomonas spp as etiological agent (OR 2.9; p < 0.05). Patients who were transferred from APD to CAPD during peritonitis therapy presented a higher risk of non-response (OR 2.5; p < 0.05). The only factor associated with death during a peritonitis episode was older age (OR 1.04; p < 0.05). Exposure to vancomycin and male gender were the independent predictors of long-term technique failure (OR 2.2; p < 0.01).
CONCLUSION: Apart from confirming previous observations of the negative impact of older age and Pseudomonas spp peritonitis on outcomes, we observed that collagenosis may negatively impact response to treatment and exposure to vancomycin may possibly reduce long-term technique survival. It is important to emphasize that the association of vancomycin with technique failure does not prove causality. These findings shed light on new factors predicting outcome when peritonitis is diagnosed.

Entities:  

Keywords:  BRAZPD; Peritoneal dialysis; clinical outcomes; peritonitis

Mesh:

Year:  2014        PMID: 24385333      PMCID: PMC3968103          DOI: 10.3747/pdi.2012.00333

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  31 in total

Review 1.  The clinical course of culture-negative peritonitis complicating peritoneal dialysis.

Authors:  Cheuk-Chun Szeto; Teresa Yuk-Hwa Wong; Kai-Ming Chow; Chi-Bon Leung; Philip Kam-Tao Li
Journal:  Am J Kidney Dis       Date:  2003-09       Impact factor: 8.860

Review 2.  Peritoneal dialysis-related infections recommendations: 2005 update.

Authors:  Beth Piraino; George R Bailie; Judith Bernardini; Elisabeth Boeschoten; Amit Gupta; Clifford Holmes; Ed J Kuijper; Philip Kam-Tao Li; Wai-Choong Lye; Salim Mujais; David L Paterson; Miguel Perez Fontan; Alfonso Ramos; Franz Schaefer; Linda Uttley
Journal:  Perit Dial Int       Date:  2005 Mar-Apr       Impact factor: 1.756

Review 3.  Bacterial community-acquired pneumonia in older patients.

Authors:  Gerald R Donowitz; Heather L Cox
Journal:  Clin Geriatr Med       Date:  2007-08       Impact factor: 3.076

4.  Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  Yui Pong Siu; Kay Tai Leung; Matthew Ka Hang Tong; Tze Hoi Kwan; Chi Chiu Mok
Journal:  Nephrol Dial Transplant       Date:  2005-10-04       Impact factor: 5.992

5.  Systemic lupus erythematosus and peritoneal dialysis: outcomes and infectious complications.

Authors:  J W Huang; K Y Hung; C J Yen; K D Wu; T J Tsai
Journal:  Perit Dial Int       Date:  2001 Mar-Apr       Impact factor: 1.756

6.  Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis.

Authors:  N Y Zalunardo; C L Rose; I W Y Ma; P Altmann
Journal:  Kidney Int       Date:  2007-02-14       Impact factor: 10.612

7.  Determinants of peritoneal dialysis technique failure in incident US patients.

Authors:  Jenny I Shen; Aya A Mitani; Anjali B Saxena; Benjamin A Goldstein; Wolfgang C Winkelmayer
Journal:  Perit Dial Int       Date:  2012-10-02       Impact factor: 1.756

8.  Culture-negative CAPD peritonitis: the Network 9 Study.

Authors:  M Bunke; M E Brier; T A Golper
Journal:  Adv Perit Dial       Date:  1994

9.  Peritonitis in Latin America.

Authors:  Pasqual Barretti; Kleyton A Bastos; Jorge Dominguez; Jacqueline C T Caramori
Journal:  Perit Dial Int       Date:  2007 May-Jun       Impact factor: 1.756

10.  Culture-negative peritonitis: a fifteen-year review.

Authors:  Kuan-Hsing Chen; Chiz-Tzung Chang; Shun-Man Weng; Chun-Chen Yu; Ji-Tseng Fang; Jeng-Yi Huang; Chih-Wei Yang; Cheng-Chieh Hung
Journal:  Ren Fail       Date:  2007       Impact factor: 2.606

View more
  9 in total

1.  Risk factors for drainage-requiring ascites after refractory peritonitis in peritoneal dialysis patients.

Authors:  Cheng-Chia Lee; Kun-Hua Tu; Hsiao-Hui Chen; Ming-Yang Chang; Cheng-Chieh Hung
Journal:  Int Urol Nephrol       Date:  2016-08-05       Impact factor: 2.370

2.  Fatigue in incident peritoneal dialysis and mortality: A real-world side-by-side study in Brazil and the United States.

Authors:  Murilo Guedes; Liz Wallim; Camila R Guetter; Yue Jiao; Vladimir Rigodon; Chance Mysayphonh; Len A Usvyat; Pasqual Barretti; Peter Kotanko; John W Larkin; Franklin W Maddux; Roberto Pecoits-Filho; Thyago Proenca de Moraes
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

3.  Is Peritonitis Risk Increased in Elderly Patients on Peritoneal Dialysis? Report from the French Language Peritoneal Dialysis Registry (RDPLF).

Authors:  Simon Duquennoy; Clémence Béchade; Christian Verger; Maxence Ficheux; Jean-Philippe Ryckelynck; Thierry Lobbedez
Journal:  Perit Dial Int       Date:  2015-12-03       Impact factor: 1.756

4.  Cardiovascular mortality in peritoneal dialysis: the impact of mineral disorders.

Authors:  César Truyts; Melani Custodio; Roberto Pecoit-Filho; Thyago Proenca de Moraes; Vanda Jorgetti
Journal:  J Bras Nefrol       Date:  2021 Apr-Jun

5.  Racial and social disparities in the access to automated peritoneal dialysis - results of a national PD cohort.

Authors:  Roberto Pecoits-Filho; Silvia Carreira Ribeiro; Adam Kirk; Helder Sebastião da Silva; Arthur Pille; Ricardo Sprenger Falavinha; Sandro Scolari Filho; Ana Elizabeth Figueiredo; Pasqual Barretti; Thyago Proença de Moraes
Journal:  Sci Rep       Date:  2017-07-12       Impact factor: 4.379

Review 6.  Peritoneal dialysis-related peritonitis: challenges and solutions.

Authors:  William L Salzer
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-06-11

7.  Phenotypic and Molecular Characterization of Nonfermenting Gram-Negative Bacilli Causing Peritonitis in Peritoneal Dialysis Patients.

Authors:  Ana Cláudia Moro Lima Dos Santos; Aydir Cecília Marinho Monteiro; Thaís Alves Barbosa; Danilo Flávio Moraes Riboli; Carlos Henrique Camargo; Adriano Martison Ferreira; Alessandro Lia Mondelli; Augusto Cezar Montelli; Rodrigo Tavanelli Hernandes; Maria de Lourdes Ribeiro de Souza da Cunha; Pasqual Barretti
Journal:  Pathogens       Date:  2022-02-08

Review 8.  ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Javier de Arteaga; Stanley Fan; Ana E Figueiredo; Douglas N Fish; Eric Goffin; Yong-Lim Kim; William Salzer; Dirk G Struijk; Isaac Teitelbaum; David W Johnson
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756

9.  A Clinical Risk Prediction Tool for Peritonitis-Associated Treatment Failure in Peritoneal Dialysis Patients.

Authors:  Surapon Nochaiwong; Chidchanok Ruengorn; Kiatkriangkrai Koyratkoson; Kednapa Thavorn; Ratanaporn Awiphan; Chayutthaphong Chaisai; Sirayut Phatthanasobhon; Kajohnsak Noppakun; Yuttitham Suteeka; Setthapon Panyathong; Phongsak Dandecha; Wilaiwan Chongruksut; Sirisak Nanta
Journal:  Sci Rep       Date:  2018-10-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.